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Background
One of the main tasks in the development of tissue engi-
neering is the advance in the design and production of
materials designed to act as support for the growing cells
and tissues. The evolution in the development of artificial
extracellular matrices (ECM) began with the use of biotol-
erated synthetic materials, mostly polymers, which
showed cell attachment and spreading capabilities of a
rather unspecific nature. Soon, these materials were
improved. Some macromolecules of natural origin were
used but more important, more specific functionalities
were included in their structure, specially peptide cell
attachment sequences.
More recently, the development of genetic engineering
has allowed the design and bioproduction of protein pol-
ymers. These are mainly made from repeating sequences
found in natural proteins, such as elastin, silks, etc., and
selected modifications [1]. One of the most promising
family of protein polymers is the Elastin-like polymers
(ELPs) which have shown an outstanding biocompatibil-
ity [2]. These polypeptides are based on the recurrence of
certain short monomers that are considered as building
blocks in the natural elastin. The most representative pol-
ymer of this family is poly (VPGVG), and the vast majority
of the ELPs described in the literature are made from
selected modifications of this pentamer or its permuta-
tion. ELPs are extremely biocompatible and bioprocessa-
ble and show and acute smart and self-assembling
behavior. Recently, the adaptation of the genetic engineer-
ing techniques to this field has opened the possibility of
obtaining these polymers with absolute control and
absence of randomness in the primary structure. This has
allowed the production of multifunctional polymers that
can combine physical, chemical and biological functions.
This works was intended as being one step more towards
the development of a complex and multifunctional artifi-
cial ECM that mimics the versatility and complexity of the
natural ECM. We describe herein the use of artificial genes
to direct the synthesis of ELPs containing cell attachment
sequences (RGD and REDV) of precisely controlled archi-
tecture and its bioproduction in E. coli [3,4].
Materials and methods
Plasmid Construction
Standard molecular biology techniques were performed
to construct two polymer genes and their sequences were
verified by automated DNA sequencing. DNA duplex
encoding the monomer genes were obtained by Polymer-
ase Chain Reaction (PCR) using two synthetic oligonucle-
otides. The first monomer gene (A) codifying the amino-
acid sequence [(VPGIG)2-(VPGKG)-(VPGIG)2]2-AVT-
GRGDSPASS- [(VPGIG)2-(VPGKG)-(VPGIG)2]2 and the
second one (B) (VPGIG)2-(VPGKG)-(VPGIG)2-EEI-
QIGHIPREDVDYHLYP-(VPGIG)2-(VPGKG)-(VPGIG)2-
(VGVAPG). After gene cloning, the monomer was
obtained by digestion, isolated and subjected to concate-
nation (controlled ligation). The concatenamer mixture
was cloned into a modified expression vector derived
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insert length by PCR colony screening and transformed
into the E. coli expression strains BL21(DE3) and
BLR(DE3). Bacterial growth and gene expression were per-
formed following the manufacturer's instructions. The
polymer purification was carried out by several cycles of
cold (4°C) and warm (50°C) centrifugation. MALDI-
TOF, amino acid analysis and spectroscopic methods
proved final polymers high purity and correct sequence.
Turbidity experiments and Differential Scanning Calorim-
etry (DSC) were used to calculate the Transition Temper-
ature (Tt) of the polymers.
Results
The bioproduced polymers comprise different building
blocks, each showing a different functionality (see Figure
1). First, the final matrix is to be designed to show a
mechanical response comparable to the natural extracel-
lular matrix, so they are produced over a base of an elas-
tin-like polymer of the type (VPGIG)n. Along with the
desired mechanical behaviour, this base has shown an
excellent biocompatibility. The second building block is a
variation of the first. It has a lysine substituting an isoleu-
cine so the lysine γ-amino group can be used for cross-
linking purposes while retaining the properties of elastin-
like polymers.
The third group contains cell attachment sequences. In
polymer A, this sequence is based the well known RGD,
while in polymer B is the CS5 human fibronectin domain,
which has the endothelial REDV cell attachment
sequence. In addition, polymer B also contains the
elastase target sequence VGVAPG to favour its bioproces-
ability by natural routes.
The polymers and the corresponding matrices (see Figure
2) have been subjected to mechanical tests, physical-
chemical, biochemical and "in vitro" analysis. The results
clearly confirm the excellent behaviour of this matrix for
the pursued purpose, as expected from the combination
of functionalities and properties of the building blocks
used in its molecular design.
Conclusion
Different recombinant elastin-like protein polymers have
been designed and bioproduced in E. coli to create
advanced scaffolds for tissue engineering. All of them con-
tain, at least, cell adhesion domains of the type RGD or
REDV, and specific protease target domains. They can be
easily cross-linked to obtain elastomeric hydrogels. These
new polymers has been subjected to mechanical tests,
physical-chemical and in vitro analysis. The results con-
firm the excellent behaviour of these matrices for this pur-
pose.
Acknowledgements
This work was supported by the "Junta de Castilla y León" (VA002/02), by 
the MEC (MAT2003-01205 and MAT2004-03484-C02-01) and by the Euro-
pean Commission (BioPolySurf MRTN-CT-2004-005516).
Photograph of a cross-linked matrix of the bioproduced B polymeFigur  2
Photograph of a cross-linked matrix of the bioproduced B 
polymer.
Schematic representation of the polymers A B architecture, identifying each building block with its corresponding amino-acid sequenceFig re 1
Schematic representation of the polymers A B architecture, identifying each building block with its corresponding amino-acid 
sequence.
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